BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 25131122)

  • 1. Evaluation of epithelial chimerism after bone marrow mesenchymal stromal cell infusion in intestinal transplant patients.
    Kilinc S; Gurkan UA; Guven S; Koyuncu G; Tan S; Karaca C; Ozdogan O; Dogan M; Tugmen C; Pala EE; Bayol U; Baran M; Kurtulmus Y; Pirim I; Kebapci E; Demirci U
    Transplant Proc; 2014; 46(6):2125-32. PubMed ID: 25131122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor-derived bone marrow transfusion produces mixed chimerism and promotes a Th2 shift in Th1/Th2 balance in rat heterotopic small bowel transplantation.
    Hu A; Li Q; Shi H; Tai Q; Wu L; Xiong J; Fu B; He X
    Dig Liver Dis; 2012 Dec; 44(12):988-94. PubMed ID: 22954489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulatory Effects of Different Cellular Therapies of Bone Marrow Origin on Chimerism Induction and Maintenance Across MHC Barriers in a Face Allotransplantation Model.
    Hivelin M; Klimczak A; Cwykiel J; Sonmez E; Nasir S; Gatherwright J; Siemionow M
    Arch Immunol Ther Exp (Warsz); 2016 Aug; 64(4):299-310. PubMed ID: 26708158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cells.
    Nakao A; Nalesnik MA; Ishikawa T; Azhipa O; Demetris AJ; Murase N
    Transplantation; 2003 May; 75(9):1575-81. PubMed ID: 12792518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Allogenic BMSCs reverse chimerism inducing the tolerance of xeno-skin graft in mouse model].
    Long D; Wu WQ; Lu J; Feng L; Li YP; Li SF
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Mar; 44(2):165-9. PubMed ID: 23745247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients.
    Garcia-Morales R; Carreno M; Mathew J; Zucker K; Cirocco R; Ciancio G; Burke G; Roth D; Temple D; Rosen A; Fuller L; Esquenazi V; Karatzas T; Ricordi C; Tzakis A; Miller J
    J Clin Invest; 1997 Mar; 99(5):1118-29. PubMed ID: 9062371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimerism of allogeneic mesenchymal cells in bone marrow, liver, and spleen after mesenchymal stem cells infusion.
    Meleshko A; Prakharenia I; Kletski S; Isaikina Y
    Pediatr Transplant; 2013 Dec; 17(8):E189-94. PubMed ID: 24164832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of donor-specific bone marrow cell infusion on chimerism and acute rejection in kidney transplantation].
    Fu YW; Wang WG; Zhou HL; Zhang WL; Yang SJ; Wang JG
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1983-5. PubMed ID: 15730811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed donor chimerism in non-malignant haematological diseases after allogeneic bone marrow transplantation.
    Shamshad GU; Ahmed S; Bhatti FA; Ali N
    J Coll Physicians Surg Pak; 2012 Dec; 22(12):765-8. PubMed ID: 23217481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation.
    Antin JH; Childs R; Filipovich AH; Giralt S; Mackinnon S; Spitzer T; Weisdorf D
    Biol Blood Marrow Transplant; 2001; 7(9):473-85. PubMed ID: 11669214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of portal infusion with donor-derived bone marrow cells and intracellular cytokine expression of graft-infiltrating lymphocytes on the graft survival in rat small bowel transplant model.
    Mitsuoka N; Iwagaki H; Ozaki M; Sheng SD; Sadamori H; Matsukawa H; Morimoto Y; Matsuoka J; Tanaka N; Yagi T
    Transpl Immunol; 2004 Nov; 13(3):155-60. PubMed ID: 15381197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of sequential and quantitative monitoring of chimerism in allogeneic hematopoietic stem cell transplantation].
    Tang XW; Wu DP; Zhu ZL; Wang W; Sun AN; Qiu HY; Fu ZZ; Chang WR; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):78-81. PubMed ID: 14990044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of chemotherapy on hematopoietic microenvironment and effect of autologous bone marrow stromal cell infusion on the recovery of hematopoiesis after chemotherapy].
    Liu J; Ji S; Zhou L; Chen H
    Zhonghua Xue Ye Xue Za Zhi; 2001 Jul; 22(7):341-3. PubMed ID: 11877093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow transplantation combined with mesenchymal stem cells induces immune tolerance without cytotoxic conditioning.
    Wang Y; Liu J; Xu C; Zhang W; Bai L; Li N; Liu Y; Wang Y; Su Y; Hu D
    J Surg Res; 2011 Nov; 171(1):e123-31. PubMed ID: 21920556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling.
    Lisini D; Zecca M; Giorgiani G; Montagna D; Cristantielli R; Labirio M; Grignani P; Previderè C; Di Cesare-Merlone A; Amendola G; Bergami E; Mastronuzzi A; Maccario R; Locatelli F
    Haematologica; 2008 Dec; 93(12):1859-67. PubMed ID: 18945748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
    J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor bone marrow infusion in deceased and living donor renal transplantation.
    Ciancio G; Burke GW; Moon J; Garcia-Morales R; Rosen A; Esquenazi V; Mathew J; Jin Y; Miller J
    Yonsei Med J; 2004 Dec; 45(6):998-1003. PubMed ID: 15627290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Utility of Quantitative PCR for Chimerism and Engraftment Monitoring after Allogeneic Stem Cell Transplantation for Hematologic Malignancies.
    Ahci M; Stempelmann K; Buttkereit U; Crivello P; Trilling M; Heinold A; Steckel NK; Koldehoff M; Horn PA; Beelen DW; Fleischhauer K
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1658-1668. PubMed ID: 28603070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Studies of Ex Vivo Expansion to Accelerate Engraftment After Umbilical Cord Blood Transplantation: A Systematic Review.
    Kiernan J; Damien P; Monaghan M; Shorr R; McIntyre L; Fergusson D; Tinmouth A; Allan D
    Transfus Med Rev; 2017 Jul; 31(3):173-182. PubMed ID: 28087163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of short tandem repeat polymorphisms for monitoring chimerism following bone marrow transplantation: a short report.
    Borrill V; Schlaphoff T; du Toit E; Marx M; Wood L; Jacobs P
    Hematology; 2008 Aug; 13(4):210-4. PubMed ID: 18796246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.